HEALTHMEDPAGE TODAY
Biomarkers for Esophageal Cancer Continue to Evolve
Biomarker discovery has been essential in developing more effective therapies for solid tumors, including esophageal cancer. The applicability of biomarkers in esophageal cancer continues to evolve.
Related Signal
Adjacent reporting
- New Strategies and Platforms for Gastroesophageal Cancer
- Evolution of Perioperative Immunotherapy in Resectable Esophageal Cancer
- Ozempic-style drugs linked to major slowdown in cancer spread, new study finds
- Blood test hints at breast-tumour response to treatment
- New drugs take aim at one of cancer’s deadliest mutations
- Molecular profiling of gene-edited cells reveals shared drug-resistance mechanisms